bisindolylmaleimide i has been researched along with Cancer of Pituitary in 3 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nanzer, AM | 1 |
Khalaf, S | 1 |
Mozid, AM | 1 |
Fowkes, RC | 1 |
Patel, MV | 1 |
Burrin, JM | 1 |
Grossman, AB | 1 |
Korbonits, M | 1 |
Wang, YH | 2 |
Maurer, RA | 2 |
Jue, SF | 1 |
3 other studies available for bisindolylmaleimide i and Cancer of Pituitary
Article | Year |
---|---|
Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway.
Topics: Androstadienes; Animals; Butadienes; Carcinogens; Cell Division; Cell Line, Tumor; Dose-Response Rel | 2004 |
A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter.
Topics: Animals; Binding Sites; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; DNA-Binding Proteins; | 1999 |
Thyrotropin-releasing hormone stimulates phosphorylation of the epidermal growth factor receptor in GH3 pituitary cells.
Topics: Animals; Enzyme Inhibitors; ErbB Receptors; Genes, Reporter; Indoles; Luciferases; Maleimides; Mitog | 2000 |